Literature DB >> 28090162

Systemic Market and Organizational Changes: Impact on P&T Committees.

F Randy Vogenberg, Rita Marcoux, Martha M Rumore.   

Abstract

The authors consider market stakeholder consolidation, market-driven efficiency demands, consumerism, and legal enforcement of patient rights related to access to appropriate drugs and posit how future P&T committees may approach these issues.

Entities:  

Keywords:  Medicare Access and CHIP Reauthorization Act; P&T; Patient Protection and Affordable Care Act; formularies; insurance; managed care; value-based reimbursement

Year:  2017        PMID： 28090162      PMCID： PMC5215276     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  3 in total

1.  The changing roles of p&t committees: a look back at the last decade and a look forward to 2020.

Authors:  F Randy Vogenberg; Judith Gomes
Journal:  P T       Date:  2014-11

2.  Using drugs to discriminate--adverse selection in the insurance marketplace.

Authors:  Douglas B Jacobs; Benjamin D Sommers
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

3.  Nondiscrimination in Health Programs and Activities. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-05-18
  3 in total
  3 in total

1.  Regulatory Change Versus Legislation Impacting Health Care Decisions and Delivery.

Authors:  F Randy Vogenberg; Mary Smart
Journal:  P T       Date:  2018-01

2.  P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.

Authors:  Laila Carolina Abu Esba; Hind Almodaimegh; Ali Alhammad; Mazen Ferwana; Consuela Yousef; Sherine Ismail
Journal:  P T       Date:  2018-05

Review 3.  Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System.

Authors:  Raghu Durvasula; Janet Kelly; Anneliese Schleyer; Bradley D Anawalt; Shabir Somani; Timothy H Dellit
Journal:  Am Health Drug Benefits       Date:  2018-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.